Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia

Published:2019-06 Issue: Volume:171 Page:221-234
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Yanxing,Dou Xiaodong^ORCID,Jiang Lan,Jin Hongwei,Zhang Lihe,Zhang Liangren,Liu Zhenming

Funder

National Natural Science Foundation of China

National Major Scientific and Technological Special Project

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference65 articles.

1. cDNA cloning and properties of glycogen synthase kinase-3;Woodgett;Methods Enzymol.,1991

2. The renaissance of GSK3;Cohen;Nat. Rev. Mol. Cell Biol.,2001

3. GSK3 takes centre stage more than 20 years after its discovery;Frame;Biochem. J.,2001

4. The many ways of Wnt in cancer;Polakis;Curr. Opin. Genet. Dev.,2007

5. GSK3 inhibitors: development and therapeutic potential;Cohen;Nat. Rev. Drug Discov.,2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of artificial intelligence in the development of anticancer therapeutics from natural polyphenols: Current advances and future prospects;Pharmacological Research;2024-10

2. Catalyzing innovation in cancer drug discovery through artificial intelligence, machine learning and patency;Pharmaceutical Patent Analyst;2024-05-21

3. Computational methods and tools for sustainable and green approaches in drug discovery;Green Approaches in Medicinal Chemistry for Sustainable Drug Design;2024

4. Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases;Mini-Reviews in Medicinal Chemistry;2023-10

5. Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells;Bioorganic Chemistry;2023-05